Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 9, 20261,200 studies indexed

July 2026

Added to Dediabetes Jul 12, 2026RCTs

Robotic surgery may improve metabolic outcomes in type 2 diabetes

This study evaluated robotic surgical strategies for managing Type 2 diabetes, showing promising outcomes in weight loss and insulin reduction.

Interventions
Sleeve gastrectomy
Outcomes
Decreased paresthesia in lower limbsHbA1cReduced insulin requirements after surgery+2 more
Added to Dediabetes Jul 12, 2026RCTs

Sarcomeal Supplement Improves Muscle Mass in Diabetic Patients

This study evaluated the efficacy of Sarcomeal supplement and vitamin D3 on muscle parameters in diabetic sarcopenia patients, revealing significant improvements in lean body mass and lean mass index.

Interventions
Vitamin D supplementation
Outcomes
Blood parametersGastrointestinal disorders incidenceHandgrip Strength+2 more
Added to Dediabetes Jul 12, 2026RCTs

Scalable diabetes education improves care coordination

This study evaluated the effectiveness of scalable diabetes self-management education and support models in adults with Type 2 Diabetes. Results showed no significant changes in key health outcomes.

Interventions
DSMES
Outcomes
BMIDiastolic blood pressureDifference in Thai-CV risk score at 12 months compared to routine care+8 more
Added to Dediabetes Jul 12, 2026RCTs

Self-Compassion Intervention Improves Glycemic Control in Young Adults with T1D

This study evaluated the impact of a self-compassion intervention on diabetes distress and glycemic control in adolescents and young adults with Type 1 diabetes, finding significant improvement in HbA1c levels.

Interventions
Instructional WhatsApp group for diabetes self-care
Outcomes
Blood glucoseDepression scoreDiabetes distress scores+5 more
Added to Dediabetes Jul 12, 2026RCTs

Semaglutide improves cardiorenal outcomes in high-risk diabetes patients

This study evaluated the cardiorenal effects of semaglutide in individuals with type 2 diabetes at high cardiovascular risk, finding significant reductions in major adverse cardiovascular events.

Interventions
Semaglutide
Outcomes
All-cause mortalityCardiovascular deathComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)+1 more
Added to Dediabetes Jul 12, 2026RCTs

Semaglutide improves cardiovascular outcomes in high-risk patients

The study evaluated semaglutide, a glucagon-like peptide-1 receptor agonist, for managing high cardiovascular risk and found significant reductions in major renal events and cardiovascular risks.

Interventions
Semaglutide
Outcomes
All-cause mortalityAnnual rate of change in eGFRCardiovascular events+2 more
Added to Dediabetes Jul 12, 2026RCTs

Semaglutide improves kidney and cardiovascular outcomes in diabetes

This study evaluated the impact of semaglutide on kidney and cardiovascular risks in individuals with type 2 diabetes and chronic kidney disease, finding significant reductions in key health outcomes.

Interventions
Semaglutide
Outcomes
AlbuminuriaAll-cause mortalityComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)+2 more
Added to Dediabetes Jul 12, 2026RCTs

Semaglutide improves vascular regenerative cell levels in diabetes

The study evaluated the effects of semaglutide on vascular regenerative cell content in individuals with type 2 diabetes, finding significant increases compared to usual care.

Interventions
SemaglutideUsual care
Outcomes
Change in vascular regenerative cell content (ALDH hi SSC low)endothelial precursors (ALDH hi SSC low CD34 + CD133 + CD45)granulocyte precursors (ALDH hi SSC hi)+2 more
Added to Dediabetes Jul 12, 2026RCTs

Semaglutide may reduce cardiovascular events in non-diabetic patients.

The study evaluated the effects of semaglutide on cardiovascular events in individuals with overweight or obesity and established cardiovascular disease without diabetes, finding a 20% reduction in major adverse cardiovascular events.

Interventions
Semaglutide
Outcomes
All-cause mortalityCardiovascular eventsCardiovascular mortality+8 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.